The Effect of MDZ on Movement During UIA Clipping

• Status: Not yet recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Midazolam

Criteria

Inclusion Criteria:

• Patients who undergo elective unruptured intracranial aneurysm clipping surgery

• American Society of Anesthesiologists grade 1,2,3

• age > 18 year old

Exclusion Criteria:

• Refuse to participate to the study

• Body Mass Index < 18.5 kg/m2 or > 35 kg/m2

• Allergic history of benzodiazepine

• Pregnant